R.I. researchers test nanoparticles in fight against rare bone cancer

By
-
TACTICAL TECH: Dr. Richard Terek, right, chief of musculoskeletal surgery at Rhode Island Hospital, and Qian Chen, director of the hospital’s Center for Biomedical Research Excellence in Skeletal Health and Repair, have developed nanoparticles to deliver medicine to limit the growth of bone cancer tumors. / PBN PHOTO/MIKE SKORSKI
TACTICAL TECH: Dr. Richard Terek, right, chief of musculoskeletal surgery at Rhode Island Hospital, and Qian Chen, director of the hospital’s Center for Biomedical Research Excellence in Skeletal Health and Repair, have developed nanoparticles to deliver medicine to limit the growth of bone cancer tumors. / PBN PHOTO/MIKE SKORSKI

For the past 26 years, Dr. Richard Terek has been treating bone cancer patients at Rhode Island Hospital in Providence. Some forms of the disease respond fairly well to treatment, but one rare type of bone cancer is notoriously resistant to intervention. Chondrosarcoma begins in the bones and spreads if not caught in time. Its

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber
  • Critical RI business news and analysis updated daily.
  • 1 year of print (26 issues).
  • Unlimited access to all subscriber only content on our website, on any device.
  • Free email alerts.
  • Annual Book of Lists Print Edition.
  • All special issues produced during subscription term.

Click Here to purchase a paywall bypass link for this article

PBN Branded Content

Rhode Island's Market Has Changed. Developers, Builders, Investors and Sellers Must Change With It.

By Emilio DiSpirito IV License Partner | Engel & Völkers Oceanside Leader | The DiSpirito…

Learn More

RELATED ARTICLESMORE FROM AUTHOR

No posts to display